GTBPVSSFWL• 12 Months (Normalized)
GTBP vs SFWL (GT Biopharma Inc. vs Shengfeng Development Limited)
Showing Closing Date Range from Sep 25, 2025 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $7.1
+832.98%
GT Biopharma Inc.
Normalized Baseline0.00%
SFWL Performance $8.48
+637.39%
Shengfeng Development Limited
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+195.59 pts
GTBP outperforming by 195.59 percentage points
GTBPSFWL
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP SFWL
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(249 dates)
| Date | GTBP Price | GTBP Gain (%) | SFWL Price | SFWL Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $7.10 | +832.98% | $8.48 | +637.39% | +195.59% |
| Sep 22, 2026 | $- | $8.83 | +667.39% | - | |
| Sep 21, 2026 | $7.18 | +843.50% | $8.48 | +637.39% | +206.11% |
| Sep 18, 2026 | $7.16 | +840.87% | $8.28 | +619.91% | +220.96% |
| Sep 17, 2026 | $7.49 | +884.23% | $9.00 | +682.17% | +202.06% |
| Sep 16, 2026 | $7.81 | +926.28% | $9.00 | +682.61% | +243.67% |
| Sep 15, 2026 | $9.00 | +1082.65% | $9.20 | +700.00% | +382.65% |
| Sep 14, 2026 | $11.63 | +1428.25% | $8.19 | +612.17% | +816.08% |
| Sep 11, 2026 | $8.61 | +1031.41% | $8.38 | +628.35% | +403.06% |
| Sep 10, 2026 | $6.18 | +712.09% | $9.48 | +724.35% | -12.26% |
| Sep 09, 2026 | $5.98 | +685.81% | $10.91 | +848.70% | -162.89% |
| Sep 04, 2026 | $0.24 | -68.33% | $0.95 | -17.39% | -50.94% |
| Sep 03, 2026 | $0.25 | -66.89% | $0.89 | -22.52% | -44.37% |
| Sep 02, 2026 | $0.28 | -62.81% | $0.89 | -22.61% | -40.20% |
| Sep 01, 2026 | $0.29 | -62.02% | $0.83 | -27.83% | -34.19% |
Page 1 of 17